Conditions: Autosomal Dominant Polycystic Kidney; ADPKD
Interventions: Drug: Bardoxolone methyl oral capsule; Drug: Placebo oral capsule
Sponsor: Reata Pharmaceuticals, Inc.
Recruiting
ClinicalTrials.gov: Nephrology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
A Trial of Bardoxolone Methyl in Patients With ADPKD – FALCON
June 3, 2019ClinicalTrials.govComments OffNephrologyADPKD | Bardoxolone | FALCON | Methyl | Patients | Trial
Comments




